Skip to content

Glomerular Filtration Rate (GFR) Reporting on Nephrology Referral Patterns by Internists

The Effect of MDRD GFR Reporting on Nephrology Referral Patterns by Internists

Status
Withdrawn
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00134797
Enrollment
0
Registered
2005-08-25
Start date
2005-02-28
Completion date
2006-02-28
Last updated
2025-08-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Kidney Disease

Keywords

GFR, serum creatinine

Brief summary

The addition of an estimate value of glomerular filtration rate (GFR) per Modification of Diet in Renal Disease \[MDRD\] (LEVEY) equation is being included and reported on all routine chemistry panels in the experimental group. The control group is only having serum creatinine, the current standard of care, reported on routine chemistry panels.

Detailed description

All patients already referred to or being followed by nephrologists were excluded. Inclusion criteria were all patients in the Internal Medicine clinic at NMCSD who were sent to the lab to obtain routine chemistry panels for follow up by their primary care providers. The primary outcome is increased referral to nephrology in accordance with NKF K/DOQI guidelines if GFR values are reported on routine chemistry panels. Key secondary outcomes are Primary Care Provider knowledge of NKF K/DOQI guidelines, specifically when patients with chronic kidney disease need to be referred to a nephrologist for further evaluation.

Interventions

None listed

Sponsors

United States Naval Medical Center, San Diego
Lead SponsorFED

Study design

Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* All patients in the Internal Medicine Clinic at Naval Medical Center, San Diego (NMCSD) who were sent to the lab to obtain follow up by their primary care providers.

Exclusion criteria

* All patients referred to or being followed by nephrologists.

Design outcomes

Primary

MeasureTime frame
Incraesed referral to nephrology inaccordance with NKF K/DOQI guidelines if GFR values are reported on routine chemistry panels.

Secondary

MeasureTime frame
Primary Care Provider knowledge of NKF K/DOQI guidelines, specifically when patients with chronic kidney disease need to be referred to a nephrologist for further evaluation.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026